scholarly journals Mobile Swab Collection Vehicle; a Blend of Necessity, Innovation, and Technology in a Resource-poor Country

2021 ◽  
Vol 18 (4) ◽  
pp. 785-788
Author(s):  
Arun Kumar Neopane ◽  
Sailendra Kumar Duwal Shrestha ◽  
Suman Raj Dangol ◽  
Bikal Shrestha ◽  
Ashis Dutta ◽  
...  

Mobile Swab Collection Vehicle is a concept that has been innovated by a team of medical and non-medical personals based upon the dire need to perform throat or nasopharyngeal swab collections to do reverse transcription polymerase chain reaction  ‘RT-PCR’ quickly, safely, and comfortably during this Corona Virus Diseases 2019, ‘COVID-19’ pandemic in a resource-poor country like Nepal. Inputs from the health care workers, beneficiaries, and engineers have been taken to construct this vehicle-mounted booth for swab collection. This vehicle is the ‘first of its kind’ in Nepal. Keywords: COVID-19; Nepal; swab collection vehicle

2021 ◽  
Vol 13 (1) ◽  
pp. 118-124
Author(s):  
Désirée Caselli ◽  
Daniela Loconsole ◽  
Rita Dario ◽  
Maria Chironna ◽  
Maurizio Aricò

The coronavirus disease 2019 (COVID-19) pandemic now represents a major threat to public health. Health care workers (HCW) are exposed to biological risk. Little is currently known about the risk of HCW operating in pediatric wards for SARS-CoV-2 infection. The aim is to assess the prevalence of SARS-CoV-2 infection in HCW in a third-level children’s hospital in Southern Italy. An observational cohort study of all asymptomatic HCW (physician, technicians, nurses, and logistic and support operators) was conducted. HCW were screened, on a voluntary basis, for SARS-CoV-2 by RT-PCR on nasopharyngeal swab performed during the first wave of COVID-19. The study was then repeated, with the same modalities, at a 7-month interval, during the “second wave” of the COVID-19 pandemic. At the initial screening between 7 and 24 April 2020, 525 HCW were tested. None of them tested positive. At the repeated screening, conducted between 9 and 20 November 2020, 627 HCW were tested, including 61 additional ones resulting from COVID-emergency recruitment. At this second screening, eight subjects (1.3%) tested positive, thus being diagnosed as asymptomatic carriers of SARS-CoV-2. They were one physician, five nurses, and two HCW from the logistic/support services. They were employed in eight different wards/services. In all cases, the epidemiological investigation showed convincing evidence that the infection was acquired through social contacts. The study revealed a very low circulation of SARS-CoV-2 infection in HCW tested with RT-PCR. All the infections documented in the second wave of epidemic of SARS-CoV-2 were acquired outside of the workplace, confirming that in a pediatric hospital setting, HCW education, correct use of personal protective equipment, and separation of the COVID-patient pathway and staff flow may minimize the risk derived from occupational exposure.


2021 ◽  
Vol 9 (8) ◽  
pp. 1738
Author(s):  
Michela Deiana ◽  
Antonio Mori ◽  
Chiara Piubelli ◽  
Francesca Perandin ◽  
Davide Treggiari ◽  
...  

SARS-CoV-2 infection was monitored in 1898 health care workers (HCWs) after receiving full vaccination with BNT162b2. Untill 30 June 2021, 10 HCWs tested positive for SARS-CoV-2 using real time RT-PCR, resulting in a 4-month cumulative incidence of 0.005%. The infection was mildly symptomatic in six (60%) and asymptomatic in four (40%) individuals. Among the infected HCWs, eight consenting individuals provided paired NPS and saliva during the course of infection, for the purpose of the analysis performed in the present study. Genomic and subgenomic viral RNAs were investigated using real-time RT-PCR in both biological specimens. The temporal profile of viral load was measured using ddPCR. Viral mutations were also analysed. Subgenomic viral RNA was detected in 8/8 (100%) NPS and in 6/8 (75%) saliva specimens at the baseline. The expression of subgenomic RNA was observed for up to 7 days in 3/8 (38%) symptomatic cases. Moreover, concordance was observed between NPS and saliva in the detection of viral mutations, and both N501Y and 69/70del (associated with the B.1.1.7 variant) were detected in the majority 6/8 (75%) of subjects, while the K417T mutation (associated with the P.1-type variants) was detected in 2/8 (25%) individuals. Overall, our findings report a low frequency of infected HCWs after full vaccination. It is, therefore, important to monitor the vaccinees in order to identify asymptomatic infected individuals. Saliva can be a surrogate for SARS-CoV-2 surveillance, particularly in social settings such as hospitals.


2020 ◽  
Author(s):  
Roberto Marchetti ◽  
Martina Stella ◽  
Debjyoti Talukdar ◽  
Rosaria Erika Pileci

ABSTRACTObjectivesSARS-CoV-2 pandemic is a health emergency for occupational healthcare workers at COVID19 hospital wards in Italy. The objective of the study was to investigate if U-Earth AIRcel bioreactors were effective in monitoring and improving air quality via detection, capture, and destruction of the SARS-CoV-2 virus, reducing the risk of transmission among healthcare workers.MethodsU-Earth AIRcel bioreactors are a demonstrated effective biomonitoring system. We implemented a methodological approach wherein they were placed at various hospitals treating COVID-19 patients in Italy. The detection of the SARS-CoV-2 virus was achieved through rapid biomonitoring testing of the solutes from the AIRcel bioreactors via SARS-CoV-2 rapid test antigen and consecutive reverse transcription-polymerase chain reaction (RT-PCR) analysis with the multiplex platform (XABT) and the Real-Time PCR Rotor-Gene.ResultsThe marked presence of the SARS-CoV-2 virus was found in multiple water samples via the detection of ORF1ab + N and/or E gene involved in gene expression and cellular signaling of the SARS-CoV virus. The AIRcel bioreactors were able to neutralize the virus effectively as traces of the viruses were no longer found in multiple solute samples after an overnight period.ConclusionsTransmission of COVID-19 via bio-aerosols, transmitted by infected patients, remains a viable threat for health workers. AIRcel bioreactors allow for rapid biomonitoring testing for early virus detection within the environment, reducing the risk of exponential contagion exposure and maintaining good air quality without endangering health workers. This same protocol can also be extended to public spaces as a bio-monitoring tool for hotpots early detection.Key messagesWhat is already known about this subject?Transmission of SARS-CoV-2 virus via bio-aerosols is a threat to health care workers. Only few studies have conducted investigations on how to limit the spread of the virus via air purifiers.Existing studies show a higher risk to health care workers serving at COVID-19 wards with a higher risk of viral transmission.What are the new findings?In this study, SARS-CoV-2 virus traces were captured by U-Earth air purifier bioreactor units placed at several hospitals in Italy.AIRcel bioreactors achieved early detection of the SARS-CoV-2 virus within the environment via rapid biomonitoring testing.AIRcel bioreactors have proved effective in biomonitoring via the detection, capture, and destruction of SARS-CoV-2 virus through reverse transcription-polymerase chain reaction (RT-PCR) analysis with the multiplex platform (XABT) Multiple Real-Time PCR Rotor-Gene.How might this impact on policy or clinical practice in the foreseeable future?This study shows the need for effective surveillance and biomonitoring to contain the spread of the SARS-CoV-2 virus. AIRcel bioreactors, an effective occupational surveillance system, can reduce the transmission of the virus to health care workers serving COVID-19 infected patients at hospital wards.AIRcel bioreactors can also be used in public spaces and other settings, such as schools, to increase the speed of detection of the SARS-CoV-2 virus and improve control of the environment, thereby decreasing the exponential growth of the pandemic.


2021 ◽  
Author(s):  
Francesca Saluzzo ◽  
Paola Mantegani ◽  
Valeria Poletti de Chaurand ◽  
Federica Cugnata ◽  
Patrizia Rovere-Querini ◽  
...  

Background Quantitative RT-PCR on NasoPharyngeal Swab (NPS) is still considered the standard for the diagnosis of SARS-CoV-2 infection, even if saliva has been evaluated in several studies as a possible alternative. The use of point of care (POC) platforms, providing highly specific results performed on saliva could simplify the diagnosis of COVID-19 and contribute to contain the spreading of SARS-CoV-2. Methods We assess the sensitivity and specificity of molecular testing performed on saliva in comparison to NPS using two different POC platforms (DiaSorin Simplexa ™ and Cepheid Xpert ®). NPS and saliva were collected prospectically from asymptomatic health care workers and mildly symptomatic patients. Moreover, the stability of saliva samples after storage at -80 C ° for up to 45 days was tested. Results The obtained results in comparison to NPS demonstrated for both DiaSorin Simplexa ™ and Xpert ® Xpress a specificity of 100% and a sensitivity of 90.24%. The overall agreement between the tests performed on saliva was 98%. A positive correlation in Ct values detected on saliva and on NPS was identified for all the targets shared by the tests in analysis (Orf1ab, E and N2). Both S Ct values and Orf1ab Ct values were not significantly different before and after the freezing in the tested saliva samples. Conclusion The obtained results demonstrated an overall performance of saliva comparable to NPS, confirming that RT-PCR performed using POCs on saliva could represent a valid public health solution for controlling SARS-CoV-2 pandemic.


Author(s):  
Amit Shrenikraj Mutha ◽  
Amit Shashikant Beldar ◽  
Shashank Desai ◽  
Nishant Kumar ◽  
Shibal Bhartiya ◽  
...  

Introduction: Health Care Workers (HCWs) can acquire or transmit Corona Virus Disease 2019 (COVID-19) from and to patients respectively. There is limited data on risk factors for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection among HCWs. Aim: To evaluate the risk factors for SARS-CoV-2 infection amongst HCWs of tertiary care hospitals in Mumbai, Maharashtra, India. Materials and Methods: A questionnaire based cross-sectional study was conducted among 801 HCWs from three tertiary care hospitals. Data regarding demography, co-morbidities (hypertension, diabetes, heart disease, cancer, immunosuppressive therapy, asthma), symptoms, contact with confirmed cases of COVID-19 and protective precautions at the work place was collected. Infection diagnosed by Respiratory Tract samples- Reverse Trancriptase Polymerase Chain Reaction (RT-PCR) test was correlated with the above factors. Results: Of the participants, 50.1% were working in designated COVID-19 area; 85.1% had no co-morbidity. A total of 62 of the 801 (7.75%) HCWs had a history of positive RT-PCR for SARS-CoV-2. Only asthma was associated with a significant higher in infection rate. Loss of taste/smell (30%), acute febrile illness (46.4%), acute respiratory illness (18.5%) were more common in persons with RT-PCR positivity (p<0.05). Visit to fever clinic, positive household member, and a definite history of exposure to a COVID-19 positive patient, were significantly associated with higher risk of infection. Working in designated COVID-19 hospital was not a significant risk factor (8.5% vs 5.6%). HCWs on Hydroxychloroquine (HCQ) prophylaxis had significantly lower rate of infection. Conclusion: Rate of SARS-CoV-2 positivity among HCWs was 7.7%. Presence of symptoms, especially, loss of taste/smell, fever and respiratory symptoms are associated with high positive rates. Working in a designated COVID hospital was not a risk factor for increased rate of infection. HCQ prophylaxis is associated with reduced rate of COVID-19 among HCWs.


2004 ◽  
Vol 18 (11) ◽  
pp. 658-664 ◽  
Author(s):  
Daniel W. Fitzgerald ◽  
Ascencio Maxi ◽  
Abdias Marcelin ◽  
Warren D. Johnson ◽  
Jean William Pape

2021 ◽  
pp. 104794
Author(s):  
Christine C. Johnson ◽  
Chad M. Coleman ◽  
Alexandra R. Sitarik ◽  
Joyce E. Leon ◽  
Robert J. Tibbetts ◽  
...  

2021 ◽  
Author(s):  
Francesca Larese Filon ◽  
Francesca Rui ◽  
Federico Ronchese ◽  
Paola Michieli ◽  
Corrado Negro

Abstract Objective To evaluate the incidence of COVID-19 infection in health care workers from the start of COVID-19 pandemic in NE of Italy, to the vaccination with BNT162b2. Materials and methods This was a retrospective cohort study. Health care workers were routinely tested for SARS-CoV-2 infections using real-time polymerase chain reaction tests in nasopharyngeal swabs. Logistic regression was used to calculate incident rate ratios (IRRs) of factors associated to COVID-19. Results A total of 4251 workers were followed-up and an annual incidence of COVID-19 of 13.6% was found. In March 2021 the incidence of infection was 4.88 and 103.55 cases for 100.000 person-days in vaccinated and non-vaccinated workers, respectively, with an adjusted IRRs of 0.05 (95% CI 0.02–0.08). Conclusions Our study evaluated the monthly incidence in health care workers in Trieste hospitals before and after the vaccination finding the protective effect of BNT162B2 vaccine in 95% of health care workers routinely tested.


MedEdPublish ◽  
2018 ◽  
Vol 7 (3) ◽  
Author(s):  
Ninos Oussi ◽  
Mitra Sadeghi ◽  
Javeria S. Qureshi ◽  
Charles Mabedi ◽  
Peter Elbe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document